Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site.... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

RFI

MENU

    RFI

    Drop in a message and we will reach out to you

    Doctor discussing with a patient while the patient reads the Package Leaflet, highlighting the importance of Product Information (PI) in the pre-authorisation stage of medicinal products. The PI includes essential details such as dosage, contraindications, and potential side effects, ensuring patient safety and effective communication. Key components like the Summary of Product Characteristics (SmPC) and labelling are crucial for healthcare professionals and patients.

    Preparation of product information

    The Importance of Product Information in Medicinal Product Pre-Authorisation

    Preparation of product information is a crucial step in the pre-authorisation stage of a medicinal product. Product Information (PI) consists of essential documents that provide officially approved and accurate information for healthcare professionals, such as doctors, nurses, and pharmacists, as well as for patients. These documents include critical details such as dosage, contraindications, and potential side effects of the medicine. The core components of the PI are the Summary of Product Characteristics (SmPC), Package Leaflet (PL), and labelling. These documents play a vital role in ensuring patient safety and effective communication of product information.

    A pharmacist discussing with a patient in a pharmacy, emphasizing the importance of accurate and clear product information (PI) in the pre-authorization stage of medicinal products. The discussion covers key aspects like dosage, contraindications, and potential side effects, reflecting SciencePharma's commitment to ensuring compliance with European guidelines through well-prepared Summary of Product Characteristics (SmPC), Package Leaflets (PL), and labelling for patient safety and effective communication.

    Comprehensive Product Information Services by SciencePharma

    At SciencePharma, we are highly attentive to the requirements outlined in the European guidelines regarding the preparation of the Product Information, as well as the graphic designs for leaflets and packaging (Module 1.3.2 CTD). This includes a focus on both immediate and outer packaging. We may support you also in the preparation of this important part of documentation.

    Our services include:

    • Preparation of Summary of Product Characteristics (SmPC), Product Leaflet (PL), and immediate & outer labelling. We prepare these documents based on the Quality Review of Documents (QRD) templates.
    • Verification of package leaflet and labelling. We thoroughly review the inner and outer labelling mock-ups for compliance with regulatory requirements, ensuring they adhere to both local and European standards.
    • Conduction of Readability Tests. We conduct these tests and prepare all necessary documentation, including protocols, questionnaires, and reports, to ensure the leaflets are understandable to patients.
    • Writing of Bridging Reports. We develop comprehensive Bridging Reports that justify the rationale for bridging, provided in a format ready for submission.
    • Translation Services. We offer professional Polish/English and English/Polish translations of the PI for registration and post-authorisation procedures.
    • Educational Materials Verification. We also verify educational materials, including Risk Management Measures (RMM), to ensure compliance and clarity.

    Our extensive experience in regulatory affairs and product information preparation allows us to support companies in navigating the complex requirements of medicinal product authorisation.

    How can we help You?

      Please be advised that the administrator of personal data entered in the above form is SciencePharma Sp. z o.o. with its registered office in Warsaw, Chełmska 30/34. These data are processed in order to receive incoming correspondence and respond to it. Providing personal data is voluntary, but necessary to send the form. Each person has the right to access their data and correct it.

      You can read the details on the protection of personal data here.